These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 1709220)
1. Characterization of distinct angiotensin II binding sites in rat adrenal gland and bovine cerebellum using selective nonpeptide antagonists. Wiest SA; Rampersaud A; Zimmerman K; Steinberg MI J Cardiovasc Pharmacol; 1991 Feb; 17(2):177-84. PubMed ID: 1709220 [TBL] [Abstract][Full Text] [Related]
2. Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa. Boulay G; Servant G; Luong TT; Escher E; Guillemette G Mol Pharmacol; 1992 Apr; 41(4):809-15. PubMed ID: 1569928 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla. Balla T; Baukal AJ; Eng S; Catt KJ Mol Pharmacol; 1991 Sep; 40(3):401-6. PubMed ID: 1654513 [TBL] [Abstract][Full Text] [Related]
4. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies. Wienen W; Mauz AB; Van Meel JC; Entzeroth M Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist. Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II receptor subtypes in the adrenals of pregnant rats. Forcier I; St-Louis J; Brochu M Mol Cell Endocrinol; 1995 Oct; 114(1-2):177-86. PubMed ID: 8674842 [TBL] [Abstract][Full Text] [Related]
7. Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands. Chang RS; Lotti VJ Mol Pharmacol; 1990 Mar; 37(3):347-51. PubMed ID: 2314387 [TBL] [Abstract][Full Text] [Related]
9. Influence of dietary sodium restriction on angiotensin II receptors in rat adrenals. Lehoux JG; Bird IM; Briere N; Martel D; Ducharme L Endocrinology; 1997 Dec; 138(12):5238-47. PubMed ID: 9389507 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor subtypes in bovine and human ventricular myocardium. Nozawa Y; Haruno A; Oda N; Yamasaki Y; Matsuura N; Yamada S; Inabe K; Kimura R; Suzuki H; Hoshino T J Pharmacol Exp Ther; 1994 Aug; 270(2):566-71. PubMed ID: 8071849 [TBL] [Abstract][Full Text] [Related]
11. In vitro pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptors. Chang RS; Lotti VJ; Chen TB; O'Malley SS; Bendesky RJ; Kling PJ; Kivlighn SD; Siegl PK; Ondeyka D; Greenlee WJ Eur J Pharmacol; 1995 Dec; 294(2-3):429-37. PubMed ID: 8750703 [TBL] [Abstract][Full Text] [Related]
12. The angiotensin hexapeptide 3-8 fragment potently inhibits [125I]angiotensin II binding to non-AT1 or -AT2 recognition sites in bovine adrenal cortex. Jarvis MF; Gessner GW; Ly CQ Eur J Pharmacol; 1992 Aug; 219(2):319-22. PubMed ID: 1425957 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin II receptor subtypes are coupled with distinct signal-transduction mechanisms in neurons and astrocytes from rat brain. Sumners C; Tang W; Zelezna B; Raizada MK Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7567-71. PubMed ID: 1881896 [TBL] [Abstract][Full Text] [Related]
14. Characterization of bovine ovary angiotensin II receptors using subtype-selective antagonists. Aiyar N; Griffin E; Edwards R; Weinstock J; Samanen J; Nambi P Pharmacology; 1993; 46(1):1-8. PubMed ID: 8434027 [TBL] [Abstract][Full Text] [Related]
15. Rabbit renal epithelial angiotensin II receptors. Dulin NO; Ernsberger P; Suciu DJ; Douglas JG Am J Physiol; 1994 Nov; 267(5 Pt 2):F776-82. PubMed ID: 7977780 [TBL] [Abstract][Full Text] [Related]
16. Characterization of renal angiotensin II receptors using subtype selective antagonists. Edwards RM; Stack EJ; Weidley EF; Aiyar N; Keenan RM; Hill DT; Weinstock J J Pharmacol Exp Ther; 1992 Mar; 260(3):933-8. PubMed ID: 1545405 [TBL] [Abstract][Full Text] [Related]
17. Analysis of angiotensin II receptor subtypes in individual rat brain nuclei. Rowe BP; Saylor DL; Speth RC Neuroendocrinology; 1992 May; 55(5):563-73. PubMed ID: 1584339 [TBL] [Abstract][Full Text] [Related]
18. Influence of tissue freezing on the binding of 125I-sarcosine1, isoleucine8 angiotensin II to angiotensin II receptor subtypes in the rat. Lu XY; Zhang W; Grove KL; Speth RC J Pharmacol Toxicol Methods; 1995 Apr; 33(2):83-90. PubMed ID: 7766920 [TBL] [Abstract][Full Text] [Related]
19. Tissue- and subtype-specific modulation of angiotensin II receptors by chronic treatment with cyclosporin A, angiotensin-converting enzyme inhibitors and AT1 antagonists. Regitz-Zagrosek V; Auch-Schwelk W; Hess B; Klein U; Duske E; Steffen C; Hildebrandt AG; Fleck E J Cardiovasc Pharmacol; 1995 Jul; 26(1):66-72. PubMed ID: 7564368 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype. Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]